Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience

Breast Journal

Volumn 11, Issue 4, 2005, Pages 242-247

  Sahoo, Sunati ^a,b   Recant, Wendy M ^a   Jaskowiak, Nora ^a   Tong, Liping ^a   Heimann, Ruth ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Breast conservation therapy; Ductal carcinoma in situ; Local recurrence

Indexed keywords

ADULT; BREAST CARCINOMA; BREAST CONSERVATION THERAPY; BREAST SURGERY; CALCIFICATION; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA IN SITU; CONTROLLED STUDY; DUCTAL CARCINOMA IN SITU; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; RADIATION DOSE; REVIEW; STATISTICAL SIGNIFICANCE; TISSUE NECROSIS; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

ADULT; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHICAGO; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS;

EID: 22644434507     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21617.x     Document Type: Review

References (27)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-18.
2. Schnitt SJ, Harris JR, Sith BL. Developing a prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2189-92.
3. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999;85:616-28.
4. Poller DN. Pathology of ductal carcinoma in situ of the breast: current status. Eur J Surg Oncol 2001;27:498-503.
5. Heimann R. The role of radiation therapy in breast cancer management. In: Ismail J, ed. Manual of Breast Diseases. Philadelphia: Lippincott Williams & Wilkins, 2002:329-52.
6. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17. Cancer 1999;86:429-38.
7. Fowble B, Hanlon AL, Fein DA, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1997;38:949-57.
8. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of age on outcome in patients with ductal carcinoma in-situ treated with breast conserving therapy. J Clin Oncol 2000;18:296-306.
9. Fisher ER, Costantino J, Fisher B, et al. Pathological findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Cancer 1995;75:310-19.
10. Weng EY, Juillard GJF, Parker RG, Chang HR, Gornbein JA. Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer 2000;88:1643-49.
11. Solin LJ, McCormick B, Recht A, et al. Mammographically detected, clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive breast irradiation. Cancer J Sci Am 1996;2:158-65.
12. Cheng L, Al-Kaisi NK, Gordon NH, Liu AY, Gebrail F, Shenk RR. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst 1997;89:1356-59.
13. Cataliotti L, Distante V, Ciatto S, et al. Intraductal breast cancer: review of 183 consecutive cases. Eur J Cancer 1992;28A:917-20.
14. Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA. Carcinoma in situ of the female breast: 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000;62:197-210.
15. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-74.
16. Delaney G, Ung O, Bilous M, Cahill S, Greenberg ML, Boyages J. Ductal carcinoma in situ. Part I: definition and diagnosis. Aust N Z Surg 1997;67:81-93.
17. Julien JP, Bijker N, Fentiman IS. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized trial 10853. Lancet 2000;355:528-33.
18. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996;14:754-63.
19. Kestin LL, Goldstein NS, Lacerna MD, et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conservation therapy. Cancer 2000;88:596-607.
20. Vicini FA, Kestin LL, Goldstein NS, et al. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast conserving therapy. J Surg Oncol 2001;76:245-54.
21. Stallard S, Hole DA, Purushotham AD, et al. Ductal carcinoma in situ of the breast-among factors predicting for recurrence, distance from the nipple is important. Eur J Surg Oncol 2001;27:373-77.
22. Faverly DRG, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-98.
23. Holland P, Gandhi A, Knox WF, et al. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer 1998;77:110-14.
24. Heimann R, Powers C, Halpern HJ, et al. Breast preservation in stage I and II carcinoma of breast: the University of Chicago experience. Cancer 1996;78:1722-30.
25. Holland R, Hendriks JHCL, Verbeek ALM, et al. Extent, distribution and mammographic/histologic correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
26. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma of the breast. N Engl J Med 1999;340:1455-61.
27. Hwang E, Samli B, Tran K, et al. Volume of resection in patients treated with breast conservation for ductal carcinoma in situ. Ann Surg Oncol 1998;5:757-63.